Collectively, nuclear IGF-1R exerts transcriptional regulation activity, and its newly discovered role in cancer provides a novel mechanism in IGF1R-mediated cancer progression and can serve as a new biomarker for predicting clinical prognosis. This evidence concerns the gene IGF1R and cancer.